Immunai vs NetraMark (2026): Pricing, Features & Which to Choose

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

Lower starting price
Not comparable
Not comparable: Immunai does not list a price
Free plan
Tie
Neither has one
Higher rating
Immunai
4.0 against 3.8
Same job?
Yes
Both are Healthcare AI tools

Side by side

Compared on	Immunai	NetraMark
Our rating	4.0Better	3.8
Starts at	Not listed	Not listed
Free plan	No	No
Category	Healthcare AI	Healthcare AI
Plans	See pricing	See pricing
Key features	AMICA-OS platform built on single-cell multi-omic immune system data Target discovery tools for identifying new drug candidates from immune cell behavior Preclinical evaluation modeling for testing target hypotheses before trials Clinical trial optimization using immune-response data One of the industry's largest clinical immunology datasets, built through 30-plus pharma partnerships	NetraAI platform for clinical trial design optimisation Optimal dosage discovery from trial data Identification of ideal treatment populations Effect size improvement analysis Late-phase decision support
Pros	Dataset scale, built through partnerships with Fortune 100 pharma companies, gives its models depth smaller labs can't replicate Covers the full pipeline from target discovery through clinical trial optimization rather than one narrow step Named partnerships with AstraZeneca, Boehringer Ingelheim, Pfizer, and Novo Nordisk demonstrate real commercial traction	Targets the design decisions that determine whether a trial succeeds Publishes an evidence base rather than claims alone Publicly listed, so financials and filings are inspectable
Cons	No published pricing; every engagement is a custom partnership negotiation Built exclusively for pharmaceutical R&D, inaccessible to academic labs or individual researchers without a deal Value depends on data-sharing arrangements with partners, which take time to negotiate and set up	No public pricing - enterprise pharma engagement Only relevant to organisations running clinical trials Findings still require clinical and regulatory validation
Company	Immunai, founded 2018	NetraMark Holdings

Prices come from each vendor's pricing page, last checked 20260831. Check the vendor before you buy.

FAQ

Questions people ask

Is Immunai better than NetraMark?

In our reviews Immunai scores 4.0 and NetraMark scores 3.8. The better pick depends on the job. Immunai: AI platform mapping the human immune system at single-cell resolution to accelerate drug discovery for pharma partners. NetraMark: NetraAI analyses clinical trial data to optimise trial design - finding optimal dosage, identifying ideal patient populations and increasing effect size.

Which is cheaper, Immunai or NetraMark?

Immunai: see pricing. NetraMark: see pricing.

Do Immunai and NetraMark have free plans?

Neither lists a free plan.

More comparisons

Immunai compared with

All Immunai alternatives

NetraMark compared with

All NetraMark alternatives